Francesco Perrone
Francesco Perrone
Istituto Nazionale Tumori di Napoli
Verified email at
TitleCited byYear
Design and endpoints of clinical trials in hepatocellular carcinoma
JM Llovet, AM Di Bisceglie, J Bruix, BS Kramer, R Lencioni, AX Zhu, ...
Journal of the National Cancer Institute 100 (10), 698-711, 2008
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial
C Gridelli, F Perrone, C Gallo, S Cigolari, A Rossi, F Piantedosi, ...
Journal of the National Cancer Institute 95 (5), 362-372, 2003
Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer
T Elderly Lung Cancer Vinorelbine Italian Study Group
Journal of the National Cancer Institute 91 (1), 66-72, 1999
High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma
L Licitra, F Perrone, P Bossi, S Suardi, L Mariani, R Artusi, M Oggionni, ...
Journal of Clinical Oncology 24 (36), 5630-5636, 2006
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases.
C Carlomagno, F Perrone, C Gallo, M De Laurentiis, R Lauria, A Morabito, ...
Journal of Clinical Oncology 14 (10), 2702-2708, 1996
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
Early Breast Cancer Trialists' Collaborative Group
The Lancet 386 (10001), 1341-1352, 2015
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy†…
P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ...
PI3KCA/PTEN deregulation contributes to impaired responses to cetuximab in metastatic colorectal cancer patients
F Perrone, A Lampis, M Orsenigo, M Di Bartolomeo, A Gevorgyan, M Losa, ...
Annals of oncology 20 (1), 84-90, 2009
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissues
MP Martelli, G Sozzi, L Hernandez, V Pettirossi, A Navarro, D Conte, ...
The American journal of pathology 174 (2), 661-670, 2009
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
N Normanno, M Di Maio, E De Maio, A De Luca, A De Matteis, A Giordano, ...
Endocrine-related cancer 12 (4), 721-747, 2005
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non–small-cell lung cancer: A phase III trial of the Italian†…
C Gridelli, C Gallo, FA Shepherd, A Illiano, F Piantedosi, SF Robbiati, ...
Journal of clinical oncology 21 (16), 3025-3034, 2003
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study
G Colucci, R Labianca, F Di Costanzo, V Gebbia, G Cartenž, B Massidda, ...
Journal of Clinical Oncology 28 (10), 1645-1651, 2010
Tyrosine kinase inhibitors of vascular endothelial growth factor receptors in clinical trials: current status and future directions
A Morabito, E De Maio, M Di Maio, N Normanno, F Perrone
The oncologist 11 (7), 753-764, 2006
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators
CLIP Group
Hepatology 28, 751-755, 1998
Elevated risk for MPNST in NF1 microdeletion patients
T De Raedt, H Brems, P Wolkenstein, D Vidaud, S Pilotti, F Perrone, ...
The American Journal of Human Genetics 72 (5), 1288-1292, 2003
Treatment of advanced non–small-cell lung cancer in the elderly: Results of an international expert panel
C Gridelli, M Aapro, A Ardizzoni, L Balducci, F De Marinis, K Kelly, ...
Journal of clinical oncology 23 (13), 3125-3137, 2005
Carboplatin-or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data
A Rossi, M Di Maio, P Chiodini, RM Rudd, H Okamoto, DV Skarlos, ...
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews†…, 2012
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
S Pignata, G Scambia, D Katsaros, C Gallo, E Pujade-Lauraine, ...
The Lancet Oncology 15 (4), 396-405, 2014
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial
C Gridelli, F Ciardiello, C Gallo, R Feld, C Butts, V Gebbia, P Maione, ...
J Clin Oncol 30 (24), 3002-3011, 2012
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials
M Di Maio, C Gridelli, C Gallo, F Shepherd, FV Piantedosi, S Cigolari, ...
The lancet oncology 6 (9), 669-677, 2005
The system can't perform the operation now. Try again later.
Articles 1–20